Cargando…
Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide
BACKGROUND: Hyponatremia in the setting of cirrhosis is a common electrolyte disorder with few therapeutic options. The free water retention is due to non-osmotic vasopressin secretion resulting from the cirrhosis-associated splanchnic vasodilatation. Therefore, vasoconstrictive therapy may correct...
Autores principales: | Patel, Sharad, Nguyen, Dai-Scott, Rastogi, Anjay, Nguyen, Minh-Kevin, Nguyen, Minhtri K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348528/ https://www.ncbi.nlm.nih.gov/pubmed/28352627 http://dx.doi.org/10.3389/fmed.2017.00017 |
Ejemplares similares
-
Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites
por: Kalambokis, Georgios N., et al.
Publicado: (2011) -
Midodrine in Liver Cirrhosis With Ascites: A Systematic Review and Meta-Analysis
por: Shrestha, Dhan B, et al.
Publicado: (2022) -
Comparison of the effect of midodrine versus octreotide on hemodynamic status in cirrhotic patients with ascites
por: Minakari, Mohammad, et al.
Publicado: (2011) -
Is the Osmolal Concentration of Ethanol Greater Than Its Molar Concentration?
por: Nguyen, Minhtri K., et al.
Publicado: (2020) -
Noradrenalin Versus the Combination of Midodrine and Octreotide in Patients with Hepatorenal Syndrome: Randomized Clinical Trial
por: Tavakkoli, Hamid, et al.
Publicado: (2012)